Dental bone grafts are implantable materials with osteogenic, osteoconductive, and osteoinductive qualities that promote bone formation, healing, and reconstruction. Bone grafting is a medical procedure using a bone graft from the patient’s body, an animal, a corpse, or someone else to replace a missing or damaged bone.
The market worth of the dental bone graft substitute market in 2021 was USD 583.60 million, and it will be worth USD 995.22 million by 2030, growing at a 6.11% CAGR during the forecast period.
A rise in the prevalence of bone and joint problems, technological developments in medicine, biocompatible synthetic bone grafts, and a growth in the demand for dental bone grafts creates commercial market prospects. However, the high cost of surgeries and moral concerns around bone grafting techniques may restrain market expansion.
The primary growth-promoting factors for the market include an increase in dental implant surgeries, an expanding target market, advances in synthetic bone graft technology, and new product introductions.
According to statistics from the Population Reference Bureau from 2018, by 2050, the number of elderly people is expected to increase from 13 to about 82 countries worldwide (65 years and above). Thus, the prevalence of periodontal diseases will rise as the number of people 60, and older continues to expand.
The increase in the cost of graft materials, membranes, implants, and replacements is responsible for higher surgical treatment expenses. Additionally, customization raises the price, which makes dental tourism more expensive.
The market for dental bone graft substitutes will flourish in the future due to the shift toward cosmetic or bone substitute dentistry. According to a recent survey, roughly 48% of people in the UK are willing to have cosmetic dental work, and 40% of people are unhappy with how their teeth look.
On the basis of material, the market for dental bone graft substitutes is segmented into autograft, alloplast, synthetic bone graft substitutes, demineralized allograft, allograft bone dental, and others.
In 2022, the xenograft segment ruled the market with a maximum share of 48.2%. A xenograft is a bone put into a human being obtained from an animal source, such as a bovine. Bio-Oss is the most often utilized xenograft. To increase penetration, major players in the market are launching new xenograft products.
The synthetic segment will grow at a robust growth of 10.6% CAGR during the forecast period. Its increased osteoconductivity, hardness, and improved acceptance are responsible for the growth.
On the basis of application, the market for dental bone graft substitutes is segmented into ridge augmentation, sinus lift, periodontal defect regeneration, socket preservation, implant bone regeneration, and implant bone regeneration.
In 2022, the socket preservation market segment held the largest market, with a share of 33.3%. It is a technique to lessen bone loss following tooth extraction from an alveolar bone tooth socket. An increase in dental implant procedures and public awareness about the importance of oral health care drives the expansion of this market.
On the basis of end-user, the market is segmented into dental clinics, hospitals, ambulatory surgical centers, and others.
In 2022, the dental clinic segment ruled the market with the largest revenue share of 76.3%. Due to their convenience and simple accessibility of surgeons, clinics are more popular as the number of dental graft surgeries each year increases. These clinics are more skilled than hospitals in providing same-day procedures that are speedier and safer. Furthermore, the industry is driven by rising oral health awareness.
In the year 2022, North America was the largest market regionally, with a share of 38.0%. An expanding target market and the number of dental implant procedures in this area drive market growth. The second-largest stake was held by Europe, which will increase profitably over the next few years.
Asia Pacific will grow at the highest rate of 10.9% CAGR during the forecast period. A surge in medical tourism and government initiatives can be blamed for the growth. The risk of dental issues is also rising in this area as the population ages.
- Danaher Corporation
- Johnson & Johnson
- RTI Surgical
- BioHorizons IPH
- Zimmer Dental
- Novabone LLC
- Botiss biomaterials GmbH
- LifeSciences Corporation
- Smith & Nephew
- Collagen Matrix Inc.
- Wright Medical
- Osteogenic Biomedical
- LifeNet Health
- Stryker Corporation
The market worth of the dental bone graft substitute market in 2021 was USD 583.60 million, and it will be worth USD 995.22 million by 2030, growing at a 6.11% CAGR during the forecast period. The primary growth factors for the market include an increase in dental implant surgeries, an expanding target market, advances in synthetic bone graft technology, and new product introductions.